These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22389324)

  • 1. Signaling pathways of immobilized FGF-2 on silicon-substituted hydroxyapatite.
    de la Concepción Matesanz M; Feito MJ; Ramírez-Santillán C; Lozano RM; Sánchez-Salcedo S; Arcos D; Vallet-Regí M; Portolés MT
    Macromol Biosci; 2012 Apr; 12(4):446-53. PubMed ID: 22389324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteostatin improves the osteogenic activity of fibroblast growth factor-2 immobilized in Si-doped hydroxyapatite in osteoblastic cells.
    Lozano D; Feito MJ; Portal-Núñez S; Lozano RM; Matesanz MC; Serrano MC; Vallet-Regí M; Portolés MT; Esbrit P
    Acta Biomater; 2012 Jul; 8(7):2770-7. PubMed ID: 22487933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immobilization and bioactivity evaluation of FGF-1 and FGF-2 on powdered silicon-doped hydroxyapatite and their scaffolds for bone tissue engineering.
    Feito MJ; Lozano RM; Alcaide M; Ramírez-Santillán C; Arcos D; Vallet-Regí M; Portolés MT
    J Mater Sci Mater Med; 2011 Feb; 22(2):405-16. PubMed ID: 21132351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-2 is an immediate-early gene induced by mechanical stress in osteogenic cells.
    Li CF; Hughes-Fulford M
    J Bone Miner Res; 2006 Jun; 21(6):946-55. PubMed ID: 16753025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular compatibility of bone-like apatite containing silicon species.
    Obata A; Kasuga T
    J Biomed Mater Res A; 2008 Apr; 85(1):140-4. PubMed ID: 17688246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of fibroblast growth factor-8 in bone cells in vitro.
    Lin JM; Callon KE; Lin JS; Watson M; Empson V; Tong PC; Grey A; Naot D; Green CR; Reid IR; Cornish J
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E142-50. PubMed ID: 19383871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fidgetin-like 1 gene inhibited by basic fibroblast growth factor regulates the proliferation and differentiation of osteoblasts.
    Park SJ; Kim SJ; Rhee Y; Byun JH; Kim SH; Kim MH; Lee EJ; Lim SK
    J Bone Miner Res; 2007 Jun; 22(6):889-96. PubMed ID: 17352653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces.
    Hossain M; Irwin R; Baumann MJ; McCabe LR
    Biomaterials; 2005 May; 26(15):2595-602. PubMed ID: 15585262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocrystallinity effects on osteoblast and osteoclast response to silicon substituted hydroxyapatite.
    Casarrubios L; Matesanz MC; Sánchez-Salcedo S; Arcos D; Vallet-Regí M; Portolés MT
    J Colloid Interface Sci; 2016 Nov; 482():112-120. PubMed ID: 27497232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitability evaluation of sol-gel derived Si-substituted hydroxyapatite for dental and maxillofacial applications through in vitro osteoblasts response.
    Balamurugan A; Rebelo AH; Lemos AF; Rocha JH; Ventura JM; Ferreira JM
    Dent Mater; 2008 Oct; 24(10):1374-80. PubMed ID: 18417203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin-hydroxyapatite for tissue engineering scaffolds.
    Kim HW; Kim HE; Salih V
    Biomaterials; 2005 Sep; 26(25):5221-30. PubMed ID: 15792549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway.
    Debiais F; Lefèvre G; Lemonnier J; Le Mée S; Lasmoles F; Mascarelli F; Marie PJ
    Exp Cell Res; 2004 Jul; 297(1):235-46. PubMed ID: 15194439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L929 fibroblast and Saos-2 osteoblast response to hydroxyapatite-betaTCP/agarose biomaterial.
    Alcaide M; Serrano MC; Pagani R; Sánchez-Salcedo S; Nieto A; Vallet-Regí M; Portolés MT
    J Biomed Mater Res A; 2009 May; 89(2):539-49. PubMed ID: 18437697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of mononuclear precursors into osteoclasts on the surface of Si-substituted hydroxyapatite.
    Botelho CM; Brooks RA; Spence G; McFarlane I; Lopes MA; Best SM; Santos JD; Rushton N; Bonfield W
    J Biomed Mater Res A; 2006 Sep; 78(4):709-20. PubMed ID: 16739170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
    Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
    J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human osteoblast response to silicon-substituted hydroxyapatite.
    Botelho CM; Brooks RA; Best SM; Lopes MA; Santos JD; Rushton N; Bonfield W
    J Biomed Mater Res A; 2006 Dec; 79(3):723-30. PubMed ID: 16871624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fibroblast growth factor 2 on osteoblastic proliferation and differentiation by regulating bone morphogenetic protein receptor expression.
    Park JB
    J Craniofac Surg; 2011 Sep; 22(5):1880-2. PubMed ID: 21959454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the osteoblastic activity conferred on Si-doped hydroxyapatite scaffolds by different osteostatin coatings.
    Manzano M; Lozano D; Arcos D; Portal-Núñez S; Orden CL; Esbrit P; Vallet-Regí M
    Acta Biomater; 2011 Oct; 7(10):3555-62. PubMed ID: 21693201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways.
    Raucci A; Bellosta P; Grassi R; Basilico C; Mansukhani A
    J Cell Physiol; 2008 May; 215(2):442-51. PubMed ID: 17960591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.